Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 3 February 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Revenue increased due in part to foreign exchange effects, but consolidated profit declined because of quality-related expenses associated with recalls and impairment losses on fixed assets in North, Central and South America. On an individual basis, net sales increased due to the effect of new products and operating profit declined because of quality-related expenses, while ordinary profit and net income increased because of higher dividends from subsidiaries and a lower corporate tax burden.
Impairment losses on fixed assets in North, Central and South America were recorded. Amount: not disclosed.
| Item | Details |
|---|---|
| Net Sales | ¥1,980,000 million → ¥2,037,063 million（+2.9%） |
| Operating profit | ¥75,000 million → ¥53,948 million（-28.1%） |
| Profit attributable to owners of the parent | ¥45,000 million → ¥23,271 million（-48.3%） |
| Net income per share | ¥251.97 → ¥130.30 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 3 February 2026 |
| Previous-period results | Previous fiscal year's individual results: net sales of ¥900,450 million, operating loss of ¥7,730 million, ordinary profit of ¥26,618 million, net income of ¥30,485 million, and earnings per share of ¥170.76. Previous fiscal year's consolidated results are not stated. |
| Reason for the revision | Revenue increased due in part to foreign exchange effects, but consolidated profit declined because of quality-related expenses associated with recalls and impairment losses on fixed assets in North, Central and South America. On an individual basis, net sales increased due to the effect of new products and operating profit declined because of quality-related expenses, while ordinary profit and net income increased because of higher dividends from subsidiaries and a lower corporate tax burden. |
| Details and amount of extraordinary loss | Impairment losses on fixed assets in North, Central and South America were recorded. Amount: not disclosed. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.On a consolidated basis, revenue increased due in part to foreign exchange effects, while profit declined because of quality-related expenses associated with recalls and impairment losses on fixed assets in North, Central and South America. On an individual basis, net sales increased due to the effect of new products and operating profit declined because of quality-related expenses, while ordinary profit and net income increased because of higher dividends from subsidiaries and a lower corporate tax burden.